Drug – bio-affecting and body treating compositions – Fermentate of unknown chemical structure – Having a known elemental analysis
Patent
1986-04-11
1988-08-16
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Fermentate of unknown chemical structure
Having a known elemental analysis
435170, A61K 3574, C12P 104
Patent
active
047645105
ABSTRACT:
Antibiotic A42125, which is produced by a new strain of Nocardia aerocolonigenes, NRRL 18049, is a useful inhibitor of Gram-positive and methane-generating microorganisms. A42125 also increases feed utilization efficiency in ruminants. A biologically purified culture of N. aerocolonigenes NRRL 18049 and a method for producing A42125 by fermentation of this culture are provided.
REFERENCES:
patent: 4524145 (1985-06-01), Matson
patent: 4552842 (1985-11-01), Nettleton et al.
ATCC Catalogue of Bacteria, Phages, rDNA Vectors, 16th ed., 1985, p. 121.
Hamill Robert L.
Kastner Ralph E.
Eli Lilly and Company
Goldberg Jerome D.
Harrison Nancy J.
Whitaker Leroy
LandOfFree
Antibiotic A42125 and process for its production does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibiotic A42125 and process for its production, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibiotic A42125 and process for its production will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-600645